/R E P E a T — Oncolytics Biotech Inc. Announces U.S. Phase 2…
Published by Food and Drug Administration News June 22nd, 2008 in UncategorizedOncolytics Biotech Inc. announced today that following U.S. Food and Drug Administration review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN in …